Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin for Acute Asthma Exacerbations (TELICAST)
NCT00273520Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2003
- Primary completion
- Apr 2004
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Telithromycin Arm with Placebo Arm (2 arms). Primary endpoints: Diary card summary symptom score at 6 weeks and Morning Peak Expiratory Flow Rate at 6 weeks. Started Jan 2003; status: completed.
02
Drugs
telithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00273520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273520.